Rhythm Pharmaceuticals (RYTM) had the highest return between June 6, 2022 and August 30, 2022 by a mid-cap US stock, returning 501.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 6/6/2022 - 8/30/2022 | 501.62% |
Axsome Therapeutics (AXSM) | 6/6/2022 - 8/30/2022 | 133.47% |
New Oriental Education & Technology (EDU) | 6/6/2022 - 8/30/2022 | 108.78% |
Verona Pharma PLC ADR (VRNA) | 6/6/2022 - 8/30/2022 | 102.87% |
Catalyst Pharmaceuticals (CPRX) | 6/6/2022 - 8/30/2022 | 87.18% |
Impinj (PI) | 6/6/2022 - 8/30/2022 | 79.98% |
TransMedics (TMDX) | 6/6/2022 - 8/30/2022 | 79.26% |
Nuvalent (NUVL) | 6/6/2022 - 8/30/2022 | 71.43% |
PTC Therapeutics (PTCT) | 6/6/2022 - 8/30/2022 | 65.29% |
Global-E Online (GLBE) | 6/6/2022 - 8/30/2022 | 61.87% |
Scholar Rock (SRRK) | 6/6/2022 - 8/30/2022 | 58.15% |
TG Therapeutics (TGTX) | 6/6/2022 - 8/30/2022 | 55.28% |
Privia Health (PRVA) | 6/6/2022 - 8/30/2022 | 54.49% |
Calix (CALX) | 6/6/2022 - 8/30/2022 | 50.91% |
TAL Education (TAL) | 6/6/2022 - 8/30/2022 | 49.17% |
Sarepta Therapeutics (SRPT) | 6/6/2022 - 8/30/2022 | 48.08% |
Celsius (CELH) | 6/6/2022 - 8/30/2022 | 47.88% |
Gitlab (GTLB) | 6/6/2022 - 8/30/2022 | 47.53% |
BridgeBio Pharma (BBIO) | 6/6/2022 - 8/30/2022 | 46.46% |
Extreme Networks (EXTR) | 6/6/2022 - 8/30/2022 | 44.55% |
Akero Therapeutics (AKRO) | 6/6/2022 - 8/30/2022 | 43.39% |
Zai Lab (ZLAB) | 6/6/2022 - 8/30/2022 | 43.15% |
ELF Beauty (ELF) | 6/6/2022 - 8/30/2022 | 42.8% |
Avidity Biosciences (RNA) | 6/6/2022 - 8/30/2022 | 42.44% |
Wingstop (WING) | 6/6/2022 - 8/30/2022 | 40.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
